PH25104A - Acyl derivatives and pharmaceutical preparation thereof - Google Patents

Acyl derivatives and pharmaceutical preparation thereof

Info

Publication number
PH25104A
PH25104A PH36758A PH36758A PH25104A PH 25104 A PH25104 A PH 25104A PH 36758 A PH36758 A PH 36758A PH 36758 A PH36758 A PH 36758A PH 25104 A PH25104 A PH 25104A
Authority
PH
Philippines
Prior art keywords
pharmaceutical preparation
acyl derivatives
acyl
derivatives
pharmaceutical
Prior art date
Application number
PH36758A
Other languages
English (en)
Inventor
Andre Dr Furlenmeier
Helmut Dr Link
Erwin Dr Gotschi
Paul Dr Hebeisen
Werner Dr Hofheinz
Original Assignee
Nippon Pharma Dev Inst
Sankei Yakuhin Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Pharma Dev Inst, Sankei Yakuhin Kk filed Critical Nippon Pharma Dev Inst
Publication of PH25104A publication Critical patent/PH25104A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
PH36758A 1987-04-10 1988-04-06 Acyl derivatives and pharmaceutical preparation thereof PH25104A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH140787 1987-04-10
CH165787 1987-04-30
CH241387 1987-06-26

Publications (1)

Publication Number Publication Date
PH25104A true PH25104A (en) 1991-02-19

Family

ID=27172951

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36758A PH25104A (en) 1987-04-10 1988-04-06 Acyl derivatives and pharmaceutical preparation thereof

Country Status (14)

Country Link
EP (1) EP0286145A3 (fi)
JP (1) JPS63258479A (fi)
KR (1) KR880012612A (fi)
AU (1) AU604868B2 (fi)
DK (1) DK179388A (fi)
FI (1) FI881650A (fi)
HU (1) HU201947B (fi)
IL (1) IL85972A0 (fi)
MC (1) MC1921A1 (fi)
NO (1) NO881531L (fi)
NZ (1) NZ224129A (fi)
PH (1) PH25104A (fi)
PT (1) PT87201A (fi)
YU (2) YU70988A (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
FI883320A (fi) * 1987-08-07 1989-02-08 Sankei Yakuhin Kk --laktam, dess framstaellning och mellanprodukter foer dess framstaellning.
US5030724A (en) * 1990-01-22 1991-07-09 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
US5077432A (en) * 1990-01-22 1991-12-31 E. R. Squibb & Sons, Inc. Monobactam hydrazides containing catechol sulfonic acid groups
EP0544166A3 (en) * 1991-11-26 1993-11-03 Hoffmann La Roche Cephalosporinderivatives
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US6200333B1 (en) 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US5972026A (en) 1997-04-07 1999-10-26 Broncus Technologies, Inc. Bronchial stenter having diametrically adjustable electrodes
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
EP2493408B1 (en) 2009-10-27 2015-06-24 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
EP2854682B1 (en) 2012-06-04 2021-06-23 Boston Scientific Scimed, Inc. Systems for treating tissue of a passageway within a body
EP2877113B1 (en) 2012-07-24 2018-07-25 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
WO2014071372A1 (en) 2012-11-05 2014-05-08 Boston Scientific Scimed, Inc. Devices for delivering energy to body lumens
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
EP3335658B1 (en) 2013-08-09 2020-04-22 Boston Scientific Scimed, Inc. Expandable catheter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485860T2 (de) * 1983-12-29 1993-01-14 Mochida Pharm Co Ltd Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
DE3687279T2 (de) * 1985-01-21 1993-05-13 Nippon Pharma Dev Inst Beta-lactam-antibiotika.
NZ215527A (en) * 1985-04-01 1989-06-28 Mochida Pharm Co Ltd Cephalosporin derivatives and pharmaceutical compositions
FI872879A (fi) * 1986-07-21 1988-01-22 Sankei Yakuhin Kk --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes.
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives

Also Published As

Publication number Publication date
PT87201A (pt) 1989-05-12
HU201947B (en) 1991-01-28
EP0286145A3 (en) 1990-10-10
NZ224129A (en) 1991-02-26
AU1430988A (en) 1988-10-13
YU123689A (en) 1991-06-30
YU70988A (en) 1989-12-31
IL85972A0 (en) 1988-09-30
DK179388A (da) 1988-10-11
FI881650A (fi) 1988-10-11
EP0286145A2 (en) 1988-10-12
JPS63258479A (ja) 1988-10-25
FI881650A0 (fi) 1988-04-08
MC1921A1 (fr) 1989-04-06
NO881531D0 (no) 1988-04-08
DK179388D0 (da) 1988-03-30
KR880012612A (ko) 1988-11-28
HUT46919A (en) 1988-12-28
AU604868B2 (en) 1991-01-03
NO881531L (no) 1988-10-11

Similar Documents

Publication Publication Date Title
PH25104A (en) Acyl derivatives and pharmaceutical preparation thereof
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
IL86502A0 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives and pharmaceutical compositions containing them
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
GR3003070T3 (en) Benzoxazole derivatives and preparation thereof
NZ220214A (en) 3-aminopyrazole derivatives and pharmaceutical compositions
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
EP0237073A3 (en) Il-1alpha derivatives and drugs
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
IL88989A0 (en) 16-dehydro-vitamin d3 derivatives their preparation and pharmaceutical compositions containing them
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
NZ216416A (en) Benzazepine derivatives and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
PH24960A (en) Acyl derivatives and pharmaceutical preparation thereof
NZ223384A (en) Benzopyran derivatives and pharmaceutical compositions
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
NZ221350A (en) Uridine derivatives and pharmaceutical preparation
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ216875A (en) 7-oxabicycloheptane derivatives and pharmaceutical compositions
NZ219250A (en) Purine derivatives and pharmaceutical compositions
IL88775A0 (en) Acyl derivatives,their manufacture and pharmaceutical compositions containing them
NZ217448A (en) Xanthine derivatives and pharmaceutical compositions
NZ226738A (en) Ginkgolide derivatives and pharmaceutical compositions